With this Relearning-based Postgraduate certificate, you will manage complex clinical cases of Multidrug-Resistant Bacterial infections and develop personalized treatment plans"

A recent report conducted by the Centers for Disease Control and Prevention reflects that more than 2.8 million antibiotic-resistant bacterial infections occur each year, resulting in more than 35,000 deaths. In response to this global threat, the scientific community has developed a number of innovative techniques ranging from basic research to clinical implementation. Faced with this, clinicians are tasked with effectively managing these strategies to combat bacterial resistance and achieve better results.  

In this context, TECH presents a cutting-edge Postgraduate certificate on Emerging Strategies Against Multidrug-Resistant Bacteria The academic itinerary will delve into CRISPR-Cas9 gene editing, taking into account key aspects such as the molecular mechanism of action. In this same line, the agenda will address how Temporal Collateral Sensitization contributes to reduce the emergence of resistance by making it difficult for bacteria to develop simultaneous resistance to multiple antibiotics. At the same time, the program will highlight the importance of vaccines to combat a wide range of pathologies caused by bacteria. In addition, graduates will gain advanced skills to effectively manage the most sophisticated bioinformatics tools to combat Multi-drug Resistant Bacteria.  

On the other hand, this university program has a 100% online mode, easily accessible from any device with Internet connection and without predetermined schedules. In this same line, TECHis based on the avant-garde teaching method of Relearning, so that doctors can go deeper into the contents without resorting to techniques that involve extra effort, such as memorization. The only thing 
professionals will only need to have an electronic device with Internet access, in order to enter the Virtual Campus and access the most complete didactic materials on the market. In this way, they will acquire both the knowledge and the 
the necessary skills to optimize their practice and experience a remarkable leap in quality in their professional careers. 

This Postgraduate Certificate in Emerging Strategies Against Multidrug-Resistant Bacteria contains the most complete and up-to-date scientific program on the market. The most important features include:

This Postgraduate certificate in Emerging Strategies Against Multidrug-Resistant Bacteria contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Microbiology, Medicine and Parasitology 
• The graphic, schematic and eminently practical contents with which it is conceived gather scientific and practical information on those disciplines that are indispensable for professional practice 
• Practical exercises where the self-assessment process can be carried out to improve learning 
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

You will learn more about High Throughput Sequencing, being able to accurately identify genetic mutations responsible for hereditary diseases"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this specializing program, as well as renowned specialists from leading societies and prestigious universities.  

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.  

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

Want to delve into the most sophisticated strategies to prevent the spread of Multidrug-Resistant Bacteria infections in healthcare settings? Get it with this program"

Study from the comfort of your home and update your knowledge online with TECH, the world's largest digital university!"

Through this university program, doctors will have a holistic understanding of the biological and genetic mechanisms that allow bacteria to maintain resistance to antibiotics. The syllabus will explore CRISPR-Cas9 gene editing in depth, enabling graduates to modify pathogens to develop better treatments for infectious diseases. Likewise, the syllabus will delve into aspects ranging from the engineering of probiotic bacteria or antibacterial vaccines to phage therapy. Therefore, professionals will gain advanced skills to develop effective clinical management strategies for infected patients.  

You will master the most innovative diagnostic techniques to identify infections caused by Multidrug-Resistant Bacteria"

Module 1. Emerging Strategies for Multidrug-Resistant Bacteria

1.1. CRISPR-Cas9 Gene Editing

1.1.1. Molecular Mechanism of Action
1.1.2. Applications

1.1.2.1. CRISPR-Cas9 as a Therapeutic Tool
1.1.2.2. Engineering of Probiotic Bacteria
1.1.2.3. Rapid Detection of Resistance
1.1.2.4. Elimination of Resistance Plasmids
1.1.2.5. Development of New Antibiotics
1.1.2.6. Safety and Stability

1.1.3. Limitations and Challenges

1.2. Temporary Collateral Sensitization (SCT)

1.2.1. Molecular Mechanism
1.2.2. Advantages and Applications of SCT
1.2.3. Limitations and Challenges

1.3. Gene Silencing

1.3.1. Molecular Mechanism
1.3.2. RNA Interference
1.3.3. Antisense Oligonucleotides
1.3.4. Benefits and Applications of Gene Silencing
1.3.5. Limitations

1.4. High-Throughput Sequencing

1.4.1. Stages of High-Throughput Sequencing
1.4.2. Bioinformatics Tools for Combating Multidrug-Resistant Bacteria
1.4.3. Challenges

1.5. Nanoparticles

1.5.1. Mechanisms of Action against Bacteria
1.5.2. Clinical Applications
1.5.3. Limitations and Challenges

1.6. Engineering of Probiotic Bacteria

1.6.1. Production of Antimicrobial Molecules
1.6.2. Bacterial Antagonism
1.6.3. Modulation of the Immune System
1.6.4. Clinical Applications

1.6.4.1. Prevention of Nosocomial Infections
1.6.4.2. Reducing the Incidence of Respiratory Infections
1.6.4.3. Adjunctive Therapy in the Treatment of Urinary Tract Infections
1.6.4.4. Prevention of Resistant Skin Infections

1.6.5. Limitations and Challenges

1.7. Antibacterial Vaccines

1.7.1. Types of Vaccines against Diseases Caused by Bacteria
1.7.2. Vaccines in Development against Major Multidrug-Resistant Bacteria
1.7.3. Challenges and Considerations

1.8. Bacteriophages

1.8.1. Mechanism of Action
1.8.2. Lytic Cycle of Bacteriophages
1.8.3. Lysogenic Cycle of Bacteriophages

1.9. Phage Therapy

1.9.1. Isolation and Transport of Bacteriophages
1.9.2. Purification and Handling of Bacteriophages in the Laboratory
1.9.3. Phenotypic and Genetic Characterisation of Bacteriophages
1.9.4. Preclinical and Clinical Trials
1.9.5. Compassionate Use of Phages and Success Stories

1.10. Antibiotic Combination Therapy

1.10.1. Mechanisms of Action
1.10.2. Efficacy and Risks
1.10.3. Challenges and Constraints
1.10.4. Combined Antibiotic and Phage Therapy

You will enjoy the most up-to-date academic content on the educational scene, available in innovative multimedia formats to optimize your study. Enroll now!”